Cargando…
Stationary phase persister formation in Escherichia coli can be suppressed by piperacillin and PBP3 inhibition
BACKGROUND: Persisters are rare phenotypic variants within a bacterial population that are capable of tolerating lethal antibiotic concentrations. Passage through stationary phase is associated with the formation of persisters (type I), and a major physiological response of Escherichia coli during s...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6591824/ https://www.ncbi.nlm.nih.gov/pubmed/31234796 http://dx.doi.org/10.1186/s12866-019-1506-7 |
_version_ | 1783429785973686272 |
---|---|
author | Aedo, Sandra J. Orman, Mehmet A. Brynildsen, Mark P. |
author_facet | Aedo, Sandra J. Orman, Mehmet A. Brynildsen, Mark P. |
author_sort | Aedo, Sandra J. |
collection | PubMed |
description | BACKGROUND: Persisters are rare phenotypic variants within a bacterial population that are capable of tolerating lethal antibiotic concentrations. Passage through stationary phase is associated with the formation of persisters (type I), and a major physiological response of Escherichia coli during stationary phase is cell wall restructuring. Given the concurrence of these processes, we sought to assess whether perturbation to cell wall synthesis during stationary phase impacts type I persister formation. RESULTS: We tested a panel of cell wall inhibitors and found that piperacillin, which primarily targets penicillin binding protein 3 (PBP3 encoded by ftsI), resulted in a significant reduction in both β-lactam (ampicillin, carbenicillin) and fluoroquinolone (ofloxacin, ciprofloxacin) persister levels. Further analyses showed that piperacillin exposure through stationary phase resulted in cells with more ATP, DNA, RNA, and protein (including PBPs) than untreated controls; and that their physiology led to more rapid resumption of DNA gyrase supercoiling activity, translation, and cell division upon introduction into fresh media. Previously, PBP3 inhibition had been linked to antibiotic efficacy through the DpiBA two component system; however, piperacillin suppressed persister formation in ΔdpiA to the same extent as it did in wild-type, suggesting that DpiBA is not required for the phenomenon reported here. To test the generality of PBP3 inhibition on persister formation, we expressed FtsI Ser307Ala to genetically inhibit PBP3, and suppression of persister formation was also observed, although not to the same magnitude as that seen for piperacillin treatment. CONCLUSIONS: From these data we conclude that stationary phase PBP3 activity is important to type I persister formation in E. coli. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12866-019-1506-7) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-6591824 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-65918242019-07-08 Stationary phase persister formation in Escherichia coli can be suppressed by piperacillin and PBP3 inhibition Aedo, Sandra J. Orman, Mehmet A. Brynildsen, Mark P. BMC Microbiol Research Article BACKGROUND: Persisters are rare phenotypic variants within a bacterial population that are capable of tolerating lethal antibiotic concentrations. Passage through stationary phase is associated with the formation of persisters (type I), and a major physiological response of Escherichia coli during stationary phase is cell wall restructuring. Given the concurrence of these processes, we sought to assess whether perturbation to cell wall synthesis during stationary phase impacts type I persister formation. RESULTS: We tested a panel of cell wall inhibitors and found that piperacillin, which primarily targets penicillin binding protein 3 (PBP3 encoded by ftsI), resulted in a significant reduction in both β-lactam (ampicillin, carbenicillin) and fluoroquinolone (ofloxacin, ciprofloxacin) persister levels. Further analyses showed that piperacillin exposure through stationary phase resulted in cells with more ATP, DNA, RNA, and protein (including PBPs) than untreated controls; and that their physiology led to more rapid resumption of DNA gyrase supercoiling activity, translation, and cell division upon introduction into fresh media. Previously, PBP3 inhibition had been linked to antibiotic efficacy through the DpiBA two component system; however, piperacillin suppressed persister formation in ΔdpiA to the same extent as it did in wild-type, suggesting that DpiBA is not required for the phenomenon reported here. To test the generality of PBP3 inhibition on persister formation, we expressed FtsI Ser307Ala to genetically inhibit PBP3, and suppression of persister formation was also observed, although not to the same magnitude as that seen for piperacillin treatment. CONCLUSIONS: From these data we conclude that stationary phase PBP3 activity is important to type I persister formation in E. coli. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12866-019-1506-7) contains supplementary material, which is available to authorized users. BioMed Central 2019-06-24 /pmc/articles/PMC6591824/ /pubmed/31234796 http://dx.doi.org/10.1186/s12866-019-1506-7 Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Article Aedo, Sandra J. Orman, Mehmet A. Brynildsen, Mark P. Stationary phase persister formation in Escherichia coli can be suppressed by piperacillin and PBP3 inhibition |
title | Stationary phase persister formation in Escherichia coli can be suppressed by piperacillin and PBP3 inhibition |
title_full | Stationary phase persister formation in Escherichia coli can be suppressed by piperacillin and PBP3 inhibition |
title_fullStr | Stationary phase persister formation in Escherichia coli can be suppressed by piperacillin and PBP3 inhibition |
title_full_unstemmed | Stationary phase persister formation in Escherichia coli can be suppressed by piperacillin and PBP3 inhibition |
title_short | Stationary phase persister formation in Escherichia coli can be suppressed by piperacillin and PBP3 inhibition |
title_sort | stationary phase persister formation in escherichia coli can be suppressed by piperacillin and pbp3 inhibition |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6591824/ https://www.ncbi.nlm.nih.gov/pubmed/31234796 http://dx.doi.org/10.1186/s12866-019-1506-7 |
work_keys_str_mv | AT aedosandraj stationaryphasepersisterformationinescherichiacolicanbesuppressedbypiperacillinandpbp3inhibition AT ormanmehmeta stationaryphasepersisterformationinescherichiacolicanbesuppressedbypiperacillinandpbp3inhibition AT brynildsenmarkp stationaryphasepersisterformationinescherichiacolicanbesuppressedbypiperacillinandpbp3inhibition |